Skip to main content
Signal8
Kanner Steven profile photo

Steven Kanner

CIK: 0001871131

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Caribou Biosciences, Inc. logo
CRBU

Caribou Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Caribou Biosciences, Inc. logo
    CRBU

    Caribou Biosciences, Inc.

    Feb 21, 2025
    Sale(S)
    Direct
    3.6K shares at avg. $1.35$5K
  • Caribou Biosciences, Inc. logo
    CRBU

    Caribou Biosciences, Inc.

    Feb 20, 2025
    Award(A)
    Direct
    37.5K shares-

1-2 of 2

About Kanner Steven

Kanner Steven (SEC CIK 0001871131) files insider reports with the SEC as Chief Scientific Officer of Caribou Biosciences, Inc. (CRBU).

Signal8 holds 1 ownership filing by Kanner Steven, a Form 4, filed on Feb 21, 2025. Those filings report 2 transactions, from Feb 20, 2025 to Feb 21, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Kanner Steven's filings is in BERKELEY, CA.

Recent filings by Kanner Steven

  • Feb 21, 2025: Open-market sale of CRBU shares (Form 4, code S).
  • Feb 20, 2025: Grant or award of CRBU shares (Form 4, code A).

Other insiders filing for Caribou Biosciences, Inc. (CRBU)

How to read Form 4 transaction codes